{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:00:32Z","timestamp":1768622432281,"version":"3.49.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA124533"],"award-info":[{"award-number":["CA124533"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA140369"],"award-info":[{"award-number":["CA140369"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/toxsci\/kfx147","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T10:14:40Z","timestamp":1499940880000},"page":"436-448","source":"Crossref","is-referenced-by-count":17,"title":["Editor\u2019s Highlight: PPAR\u03b2\/\u03b4 and PPAR\u03b3 Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis"],"prefix":"10.1093","volume":"159","author":[{"given":"Michael G.","family":"Borland","sequence":"first","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, The Center of Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802"},{"name":"Department of Chemistry and Biochemistry, Bloomsburg University of Pennsylvania, Bloomsburg, Pennsylvania 17815"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Li","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, The Center of Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen M.","family":"Kehres","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Bloomsburg University of Pennsylvania, Bloomsburg, Pennsylvania 17815"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, The Center of Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Pritzlaff","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Bloomsburg University of Pennsylvania, Bloomsburg, Pennsylvania 17815"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Ola","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Bloomsburg University of Pennsylvania, Bloomsburg, Pennsylvania 17815"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley L.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Bloomsburg University of Pennsylvania, Bloomsburg, Pennsylvania 17815"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke E.","family":"Shannon","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Bloomsburg University of Pennsylvania, Bloomsburg, Pennsylvania 17815"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajakta P.","family":"Albrecht","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, The Center of Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bokai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, The Center of Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boo-Hyon","family":"Kang","sequence":"additional","affiliation":[{"name":"Non-clinical Research Institute, Chemon, Yangji-Myeon, Cheoin-Gu, Yongin-Si, Gyeonggi-Do 17162, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin P.","family":"Robertson","sequence":"additional","affiliation":[{"name":"Departments of Pharmacology, Pathology, Dermatology, Surgery, The Melanoma and Skin Cancer Center, and The Melanoma Therapeutics Program, The Pennsylvania State University, Hershey, Pennsylvania 17033;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Laboratory of Metabolism, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Biomedical Sciences, The Center of Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"key\n\t\t\t\t20180328162715_kfx147-B1","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/sj.bjc.6604306","article-title":"An immunohistochemical perspective of PPAR\u03b2 and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours","volume":"98","author":"Ahmed","year":"2008","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tem.2009.08.006","article-title":"Genome-wide mechanisms of nuclear receptor action","volume":"21","author":"Biddie","year":"2010","journal-title":"Trends Endocrinol. Metab"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B3","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1124\/mol.108.050609","article-title":"Ligand activation of peroxisome proliferator-activated receptor-\u03b2\/\u03b4 inhibits cell proliferation in human HaCaT keratinocytes","volume":"74","author":"Borland","year":"2008","journal-title":"Mol. Pharmacol"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B4","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.cellsig.2011.07.020","article-title":"Stable over-expression of PPAR\u03b2\/\u03b4 and PPAR\u03b3 to examine receptor signaling in human HaCaT keratinocytes","volume":"23","author":"Borland","year":"2011","journal-title":"Cell. Signal"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/jid.2008.346","article-title":"In vitro and invivo anti-melanoma effects of ciglitazone","volume":"129","author":"Botton","year":"2009","journal-title":"J. Invest. Dermatol"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B6","doi-asserted-by":"crossref","first-page":"695797.","DOI":"10.1155\/2014\/695797","article-title":"Inhibition of peroxisome proliferator-activated receptor \u03b3 prevents the melanogenesis in murine B16\/F10 melanoma cells","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"key\n\t\t\t\t20180328162715_kfx147-B7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1097-2765(02)00646-9","article-title":"Antiapoptotic role of PPAR\u03b2 in keratinocytes via transcriptional control of the Akt1 signaling pathway","volume":"10","author":"Di-Poi","year":"2002","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s11095-007-9524-9","article-title":"PPAR\u03b1\/\u03b3 expression and activity in mouse and human melanocytes and melanoma cells","volume":"25","author":"Eastham","year":"2008","journal-title":"Pharm. Res"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04333","article-title":"An open investigation of the reproducibility of cancer biology research","volume":"3","author":"Errington","year":"2014","journal-title":"Elife"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mc.20757","article-title":"Functional characterization of peroxisome proliferator-activated receptor-\u03b2\/\u03b4 expression in colon cancer","volume":"50","author":"Foreman","year":"2011","journal-title":"Mol. Carcinog"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B11","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells invitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejso.2016.07.145","article-title":"Immunotherapy in melanoma: Recent advances and future directions","volume":"43","author":"Franklin","year":"2016","journal-title":"Eur. J. Surg. Oncol"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00001813-200603000-00011","article-title":"Anti-proliferative effect of peroxisome proliferator-activated receptor \u03b3 agonists on human malignant melanoma cells invitro","volume":"17","author":"Freudlsperger","year":"2006","journal-title":"Anticancer Drugs"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B14","doi-asserted-by":"crossref","first-page":"503797.","DOI":"10.1155\/2008\/503797","article-title":"The critical role of PPAR\u03b3 in human malignant melanoma","volume":"2008","author":"Freudlsperger","year":"2008","journal-title":"PPAR Res."},{"key":"key\n\t\t\t\t20180328162715_kfx147-B15","first-page":"207","article-title":"The proteasome inhibitor bortezomib augments anti-proliferative effects of mistletoe lectin-I and the PPAR-\u03b3 agonist rosiglitazone in human melanoma cells","volume":"27","author":"Freudlsperger","year":"2007","journal-title":"Anticancer Res"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B16","doi-asserted-by":"crossref","first-page":"18721","DOI":"10.1073\/pnas.0609025103","article-title":"Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness","volume":"103","author":"Galaup","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tox.2007.10.023","article-title":"Peroxisome proliferator-activated receptor-\u03b2\/\u03b4 (PPAR\u03b2\/\u03b4) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines","volume":"243","author":"Girroir","year":"2008","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B18","doi-asserted-by":"crossref","first-page":"631.","DOI":"10.1016\/j.bbagrm.2012.05.002","article-title":"Chromatin in time and space","volume":"1819","author":"Hager","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B19","first-page":"674","article-title":"Ligand-activated PPAR\u03b4 modulates the migration and invasion of melanoma cells by regulating Snail expression","volume":"4","author":"Ham","year":"2014","journal-title":"Am. J. Cancer Res"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-8674(00)81664-5","article-title":"PPAR\u03b4 is an APC-regulated target of nonsteroidal anti-inflammatory drugs","volume":"99","author":"He","year":"1999","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B21","doi-asserted-by":"crossref","first-page":"R147.","DOI":"10.1186\/gb-2007-8-7-r147","article-title":"Meta-analysis of primary target genes of peroxisome proliferator-activated receptors","volume":"8","author":"Heinaniemi","year":"2007","journal-title":"Genome Biol"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B22","article-title":"SEER Cancer Statistics Review, 1975-2013","author":"Howlader","year":"2016","journal-title":"National Cancer Institute"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2133.2004.05844.x","article-title":"Expression and function of peroxisome proliferator-activated receptors in human melanocytes","volume":"150","author":"Kang","year":"2004","journal-title":"Br. J. Dermatol"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B24","doi-asserted-by":"crossref","first-page":"16.","DOI":"10.1186\/1476-4598-8-16","article-title":"Retinoid and thiazolidinedione therapies in melanoma: An analysis of differential response based on nuclear hormone receptor expression","volume":"8","author":"Klopper","year":"2009","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B25","doi-asserted-by":"crossref","first-page":"729876.","DOI":"10.1155\/2010\/729876","article-title":"Combination PPAR\u03b3 and RXR agonist treatment in melanoma cells: functional importance of S100A2","volume":"2010","author":"Klopper","year":"2010","journal-title":"PPAR Res."},{"key":"key\n\t\t\t\t20180328162715_kfx147-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcb.2013.12.002","article-title":"Oncogenes in melanoma: An update","volume":"93","author":"Kunz","year":"2014","journal-title":"Eur. J. Cell Biol"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B27","first-page":"848645.","article-title":"Cyclooxygenase 2 (COX2) and peroxisome proliferator-activated receptor gamma (PPARG) are stage-dependent prognostic markers of malignant melanoma","volume":"2009","author":"Meyer","year":"2010","journal-title":"PPAR Res."},{"key":"key\n\t\t\t\t20180328162715_kfx147-B28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00424-009-0776-6","article-title":"PPAR\u03b2 activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1","volume":"459","author":"Michiels","year":"2010","journal-title":"Pflugers Arch"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1523-1747.2002.01861.x","article-title":"Agonists of peroxisome proliferator-activated receptor \u03b3 inhibit cell growth in malignant melanoma","volume":"119","author":"Mossner","year":"2002","journal-title":"J. Invest. Dermatol"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2005.05.009","article-title":"PPAR-\u03b3 ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells","volume":"236","author":"Nunez","year":"2006","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B31","first-page":"1083","article-title":"Enhanced effects of PPAR\u03b3 ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells","volume":"21","author":"Papi","year":"2009","journal-title":"Oncol. Rep"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B32","doi-asserted-by":"crossref","first-page":"e46103","DOI":"10.1371\/journal.pone.0046103","article-title":"Proteome analysis identified the PPAR\u03b3 ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction","volume":"7","author":"Paulitschke","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B33","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","article-title":"Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow","volume":"92","author":"Pear","year":"1998","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B34","first-page":"230","article-title":"Sorting out the functional role(s) of peroxisome proliferator-activated receptor-\u03b2\/\u03b4 (PPAR\u03b2\/\u03b4) in cell proliferation and cancer","volume":"1796","author":"Peters","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tem.2015.09.004","article-title":"Establishing the Role of PPAR\u03b2\/\u03b4 in Carcinogenesis","volume":"26","author":"Peters","year":"2015","journal-title":"Trends Endocrinol. Metab"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3214","article-title":"The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention","volume":"12","author":"Peters","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40495-015-0026-x","article-title":"Targeting peroxisome proliferator-activated receptor-\u03b2\/\u03b4 (PPAR\u03b2\/\u03b4) for cancer chemoprevention","volume":"1","author":"Peters","year":"2015","journal-title":"Curr. Pharmacol. Rep."},{"key":"key\n\t\t\t\t20180328162715_kfx147-B38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00008390-200310000-00003","article-title":"The effect of PPAR\u03b3 ligands on the proliferation and apoptosis of human melanoma cells","volume":"13","author":"Placha","year":"2003","journal-title":"Melanoma Res"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B39","first-page":"3647","article-title":"Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells","volume":"29","author":"Sertznig","year":"2009","journal-title":"Anticancer Res"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00128071-200809010-00002","article-title":"Peroxisome proliferator-activated receptors (PPARs) and the human skin: Importance of PPARs in skin physiology and dermatologic diseases","volume":"9","author":"Sertznig","year":"2008","journal-title":"Am. J. Clin. Dermatol"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B41","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1073\/pnas.052707099","article-title":"The peroxisome proliferator-activated receptor \u03b4, an integrator of transcriptional repression and nuclear receptor signaling","volume":"99","author":"Shi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B42","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.18632\/oncotarget.1892","article-title":"Pathways and therapeutic targets in melanoma","volume":"5","author":"Shtivelman","year":"2014","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B44","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/onc.2011.299","article-title":"Peroxisome proliferator-activated receptor \u03b4 confers resistance to peroxisome proliferator-activated receptor \u03b3-induced apoptosis in colorectal cancer cells","volume":"31","author":"Wang","year":"2012","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B45","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/mc.22607","article-title":"Peroxisome proliferator-activated receptor-\u03b2\/\u03b4 inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation","volume":"56","author":"Yao","year":"2017","journal-title":"Mol. Carcinog"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B46","doi-asserted-by":"crossref","first-page":"36319","DOI":"10.18632\/oncotarget.5415","article-title":"Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-\u03b2\/\u03b4- and retinoic acid receptor-dependent mechanisms","volume":"6","author":"Yao","year":"2015","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B47","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1535-7163.MCT-13-0836","article-title":"Activation of peroxisome proliferator-activated receptor-\u03b2\/\u03b4 (PPAR-\u03b2\/\u03b4) inhibits human breast cancer cell line tumorigenicity","volume":"13","author":"Yao","year":"2014","journal-title":"Mol. Cancer Ther"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/pcmr.12459","article-title":"The genomic landscape of cutaneous melanoma","volume":"29","author":"Zhang","year":"2016","journal-title":"Pigment. Cell Melanoma Res."},{"key":"key\n\t\t\t\t20180328162715_kfx147-B49","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1038\/onc.2013.477","article-title":"PPAR\u03b2\/\u03b4 promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling","volume":"33","author":"Zhu","year":"2014","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180328162715_kfx147-B50","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1128\/MCB.00092-12","article-title":"Peroxisome proliferator-activated receptor \u03b2\/\u03b4 cross talks with E2F and attenuates mitosis in HRAS-expressing cells","volume":"32","author":"Zhu","year":"2012","journal-title":"Mol. Cell. Biol"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/159\/2\/436\/24195209\/kfx147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T05:50:46Z","timestamp":1602481846000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/159\/2\/436\/3965332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,7,14]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfx147","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,7,14]]}}}